NEW YORK (Reuters Health) – Intravaginal progesterone is a valid alternative to intramuscular administration for luteal phase support in women undergoing in vitro fertilization, according to the results…
NEW YORK (Reuters Health) – While the CYP2C19 genotype is associated with platelet response to clopidogrel, that does not equate with any meaningful effect on clinical outcomes, according…
NEW YORK (Reuters Health) – In patients presenting with chest pain, troponin I levels measured on admission and at 3 hours reliably rule out or rule in acute…
NEW YORK (Reuters Health) – A pooled analysis of two trials indicates that HIV patients with aggressive B-cell non-Hodgkin lymphoma (NHL) fare better with a regimen of rituximab…
NEW YORK (Reuters Health) – Analysis of the ST segment on the fetal electrocardiogram combined with conventional cardiotocography during intrapartum monitoring reduces the rate of operative vaginal deliveries…
NEW YORK (Reuters Health) – Overall outcomes of drug-eluting coronary stent (DES) implantation are statistically no worse with 6 months of dual antiplatelet therapy than with 12 months,…
“The rule has shown consistent performance in different settings. Hence, it can be used with confidence,” Dr. Subhash Chandra, who was involved in the analysis, told Reuters Health.PERC…
NEW YORK (Reuters Health) – In populations with low prevalence of latent tuberculosis infection, the majority of positive results on the tuberculin skin test (TST) and the newer…
NEW YORK (Reuters Health) – The optimum timing for planned delivery of uncomplicated monochorionic and dichorionic twin pregnancies is unclear. New research suggests that, with close fetal surveillance,…
NEW YORK (Reuters Health) – In pregnant HIV-infected women treated with a single intrapartum dose of nevirapine (NVP) to prevent vertical HIV transmission, the subsequent selection of nevirapine-resistant…
NEW YORK (Reuters Health) – Rituximab monotherapy is “a very good option” for severe cryoglobulinemic vasculitis (CV), according to the authors of an Italian study published online December…
NEW YORK (Reuters Health) – Moxifloxacin is as effective as amoxicillin/clavulanic acid in the treatment of exacerbations of chronic obstructive pulmonary disease (COPD) in the outpatient setting, according…
